AMY HANFORD: Open Payments
NPI 1699152900 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 71 payments from 26 companies in 2025. Trend: 2023 $144 · 2024 $576 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $193 |
| Abbott Laboratories | 8 | $171 |
| Amgen Inc. | 12 | $157 |
| Novo Nordisk Inc | 7 | $134 |
| Aimmune Therapeutics, Inc. | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| ABBVIE INC. | 3 | $65 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
Products named: BREZTRI, OTEZLA, ZENPEP, Kerendia, GEMTESA, AIRSUPRA, GOMEKLI, JOT DX.
Industry payments across AZ — which companies pay providers there.
